Label-free isolation of prostate cancer cells using a spiral microfluidic chip
Prostate cancer is one of the most common cancers among men. Early detection of prostate cancer prevents malignancy and leads to a nearly 100% survival rate whereas late diagnosis reduces it to ~28%. Currently, the gold standard for testing prostate cancer is measuring the prostate-specific...